Ubs Group Ag Brainsway Ltd. Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Brainsway Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 593 shares of BWAY stock, worth $4,785. This represents 0.0% of its overall portfolio holdings.

Number of Shares

593

Previous 2,133 72.2%

Holding current value

$4,785

Previous $11,000 72.73%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$4.75 - $7.08 $7,315 - $10,903	-1,540 Reduced 72.2%	593 $3,000
Q1 2024 May 13, 2024	SELL	$5.25 - $7.46 $37,038 - $52,630	-7,055 Reduced 76.78%	2,133 $11,000
Q4 2023 Feb 09, 2024	BUY	$3.16 - $7.07 $29,034 - $64,959	9,188 New	9,188 $59,000
Q3 2022 Nov 10, 2022	SELL	$3.53 - $6.9 $116 - $227	-33 Reduced 9.02%	333 $1,000
Q2 2022 Aug 10, 2022	SELL	$4.5 - $8.96 $2,160 - $4,300	-480 Reduced 56.74%	366 $2,000
Q1 2022 May 16, 2022	BUY	$7.08 - $8.88 $736 - $923	104 Added 14.02%	846 $7,000
Q4 2021 Feb 14, 2022	BUY	$7.09 - $8.7 $5,260 - $6,455	742 New	742 $6,000
Q2 2021 Aug 13, 2021	SELL	$8.25 - $11.62 $8,464 - $11,922	-1,026 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$7.08 - $10.03 $474 - $672	67 Added 6.99%	1,026 $9,000
Q4 2020 Feb 11, 2021	BUY	$5.58 - $7.54 $1,908 - $2,578	342 Added 55.43%	959 $7,000
Q3 2020 Nov 12, 2020	BUY	$5.52 - $8.0 $910 - $1,320	165 Added 36.5%	617 $4,000
Q2 2020 Jul 31, 2020	BUY	$5.89 - $8.55 $300 - $436	51 Added 12.72%	452 $3,000
Q1 2020 May 01, 2020	BUY	$5.23 - $12.31 $162 - $381	31 Added 8.38%	401 $3,000
Q4 2019 Feb 14, 2020	BUY	$8.3 - $10.83 $3,071 - $4,007	370 New	370 $4,000
Q3 2019 Nov 14, 2019	SELL	$8.55 - $10.8 $18,194 - $22,982	-2,128 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$8.66 - $11.5 $18,428 - $24,472	2,128 New	2,128 $22,000

Others Institutions Holding BWAY

# of Institutions

Shares Held

3.58M

Call Options Held

Put Options Held

View Full List

About Brainsway Ltd.

Ticker BWAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 16,519,200
Market Cap $133M
Description
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...

More about BWAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account